Moreover, changes in IP3R1 have been implicated in the biological properties of the tumors: for example, cisplatin-induced downregulation of IP3R1 expression was found to be associated with the acquisition of cisplatin resistance in bladder cancer cell lines (Tsunoda et al. 2005). Here, ITPR1 is linked to urinary bladder cancer.